BioSpace News Archive

FDA

Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of Eosinophilic Esophagitis (EoE)

Arena Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation status to etrasimod.

June 9, 2021
·
5 min read
Drug Development

Results from Qu Biologics’ Crohn’s Disease RESTORE Trial Selected for Oral Presentation at ECCO 2021

Qu Biologics Inc. is pleased to announce that the data from QBECO-CD-02, Qu’s Phase 2 study of QBECO SSI treatment for Crohn’s disease, was selected for an oral presentation at the 16th Congress of European Crohn’s and Colitis Organization, a leading GI conference.

June 9, 2021
·
4 min read
Sunshine Biopharma Mice Study for COVID-19 Treatment Progressing as Planned

Sunshine Biopharma Inc., a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, confirmed that its COVID-19 mice study currently underway at the University of Georgia is progressing as planned.

June 9, 2021
·
4 min read
Drug Development

Synaptogenix Announces Phase 2b NIH Sponsored Alzheimer’s Disease Trial Update

Synaptogenix, Inc. today announced an update on its ongoing National Institutes of Health (“NIH”) sponsored Phase 2b clinical trial f Bryostatin-1 in patients suffering from moderately severe Alzheimer’s disease.

June 9, 2021
·
4 min read
Genetown

Navigation Sciences™ Begins First-in-Human Clinical Feasibility Trial of its Pioneering, NaviSci™ System for Tissue-Conserving Removal of Early-Stage Lung Tumors

Navigation Sciences announced that the initial patient has participated in the first-in-human clinical feasibility trial of its NaviSci™ System for use in minimally invasive surgery to remove probable early-stage lung tumors.

June 9, 2021
·
3 min read
Lone Star Bio

Texas Children’s Hospital Center for Vaccine Development COVID-19 Subunit Vaccine Candidate Advancing Towards Global Access

Texas Children’s Hospital and Baylor College of Medicine leading COVID-19 subunit vaccine candidate, developed with Biological E. Limited, a Hyderabad-based vaccine and pharmaceutical company, has received approval to proceed with Phase III clinical trials in India.

June 9, 2021
·
3 min read
Genetown

LeMaitre to Present at the Goldman Sachs Virtual Global Healthcare Conference

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Goldman Sachs 42nd Annual Virtual Global Healthcare Conference on Thursday, June 10, 2021, at 5:30 PM ET.

June 9, 2021
·
1 min read
Biopsy Devices Market Surpass US$ 3,584.20 million by 2027 COVID-19 Impact and Global Analysis by The Insight partners

The report highlights trends prevailing in the global biopsy devices market with the factors driving the market growth and those hampering it.

June 9, 2021
·
5 min read
Hemostats Market An increasing number of surgical procedures

The report highlights the trends prevalent in the global hemostats market and the factors driving the market along with those that act as deterrents to its growth.

June 9, 2021
·
5 min read
Medical Cyclotron Market Growing Inclination Toward Nuclear Scans for Accurate Diagnosis

The increasing prevalence of cancer and growing inclination toward nuclear scans for accurate diagnosis are the key forces driving the market growth.

June 9, 2021
·
6 min read